20811895

Source:http://linkedlifedata.com/resource/pubmed/id/20811895

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0045093, umls-concept:C0205179, umls-concept:C0282460, umls-concept:C0750952, umls-concept:C0879262, umls-concept:C1521750
pubmed:issue	6
pubmed:dateCreated	2011-5-26
pubmed:abstractText	We aimed to evaluate the efficacy and safety of gemcitabine/S-1 combination chemotherapy for the treatment of patients with advanced biliary tract cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1432-0843
pubmed:author	pubmed-author:AsadaMasanoriM, pubmed-author:COXP JPJ, pubmed-author:ChibaTsutomuT, pubmed-author:FukushimaMasanoriM, pubmed-author:HamadaAkihikoA, pubmed-author:HatanoEtsuroE, pubmed-author:InoueNaoyaN, pubmed-author:KanaiMasashiM, pubmed-author:MatsumotoShigemiS, pubmed-author:MoriYukikoY, pubmed-author:NiimiMiyukiM, pubmed-author:NishimuraTakafumiT, pubmed-author:NittaTakashiT, pubmed-author:OsakiYukioY, pubmed-author:SuzukiChihiroC, pubmed-author:TadaShinsukeS, pubmed-author:TauraKojiroK, pubmed-author:TsumuraTakehikoT, pubmed-author:UemotoShinjiS, pubmed-author:YanagiharaKazuhiroK, pubmed-author:YasuchikaKentaroK, pubmed-author:YazumiShujiroS, pubmed-author:YoshimuraKenichiK
pubmed:issnType	Electronic
pubmed:volume	67
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1429-34
pubmed:meshHeading	pubmed-meshheading:20811895-Adult, pubmed-meshheading:20811895-Aged, pubmed-meshheading:20811895-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20811895-Biliary Tract Neoplasms, pubmed-meshheading:20811895-Deoxycytidine, pubmed-meshheading:20811895-Disease-Free Survival, pubmed-meshheading:20811895-Drug Combinations, pubmed-meshheading:20811895-Female, pubmed-meshheading:20811895-Humans, pubmed-meshheading:20811895-Male, pubmed-meshheading:20811895-Middle Aged, pubmed-meshheading:20811895-Neoplasm Metastasis, pubmed-meshheading:20811895-Neoplasm Recurrence, Local, pubmed-meshheading:20811895-Oxonic Acid, pubmed-meshheading:20811895-Tegafur
pubmed:year	2011
pubmed:articleTitle	A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.
pubmed:affiliation	Outpatient Oncology Unit, Kyoto University Hospital, 54 Shogoin-Kawahara-cho Sakyo-ku, Kyoto, Japan. kanai@kuhp.kyoto-u.ac.jp
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II